Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Avi Kapoor

UNCOVERED: These analysts slash their forecasts on altimmune following q2 results | History Defined

Crypto,Trader,Investor,Broker,Using,Smartphone,App,Analyzing,Financial,Data

Altimmune, Inc. (NASDAQ:ALT) posted a loss for the second quarter on Tuesday.

The company posted a quarterly loss of 27 cents per share, versus market estimates of a loss of 32 cents per share. The company's quarterly sales came in at $5.000K.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.